Market Introduction
Drug delivery systems are the technologies primarily used for the controlled or targeted delivery of various therapeutic agents to treat various diseases or improve the health of the patients. Nasal drug delivery is one of the efficient routes of drug administration. It offers needle-free drug delivery, optimal route for brain-targeted therapies, and superior bioavailability. Nasal route of administration is preferred in several disease indications such as Parkinson’s disease, prostate cancer, migraine, and influenza amongst others. Moreover, nasal route is also suitable for the treatment of drug addiction as well as for sedation.
Market Overview and Dynamics
The South and Central America nasal delivery devices market is expected to reach US$ 7,548.89 million in 2027 from US$ 4,916.69 million in 2019. The market is estimated to grow with a CAGR of 5.6% from 2020-2027. The growth of the market is attributed to some key driving factors such as the increasing geriatric population across South and Central America and the growing burden of non-communicable diseases. However, the market growth is likely to be hindered owing to the concerns related to the administration of the nasal delivery medications.
Key Market Segments
Based on drug type, the nasal delivery devices market is anaesthetics, antibiotics, pain relief drugs, calcium supplements, vasoconstrictors, antihistamines, and others. Based on delivery technologies, the nasal delivery devices market, is segmented into spray, nebulizers, inhalers, and others. Based on end user, the nasal delivery devices market, is segmented into home care settings, hospitals, and clinics.
Major Sources and Companies Listed
Some of the major primary and secondary sources for nasal delivery devices market included in the report are Brazil Statistical Institute, GLOBOCAN, and others.
Reasons to buy the report
SOUTH AND CENTRAL AMERICA NASAL DELIVERY DEVICES MARKET SEGMENTATION
By Country
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 4,916.69 Million |
| Market Size by 2027 | US$ 7,548.89 Million |
| CAGR (2020 - 2027) | 5.6% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Drug Type
|
| Regions and Countries Covered |
South and Central America
|
| Market leaders and key company profiles |
|
The South and Central America Nasal Delivery Devices Market is valued at US$ 4,916.69 Million in 2019, it is projected to reach US$ 7,548.89 Million by 2027.
As per our report South and Central America Nasal Delivery Devices Market, the market size is valued at US$ 4,916.69 Million in 2019, projecting it to reach US$ 7,548.89 Million by 2027. This translates to a CAGR of approximately 5.6% during the forecast period.
The South and Central America Nasal Delivery Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Nasal Delivery Devices Market report:
The South and Central America Nasal Delivery Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South and Central America Nasal Delivery Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South and Central America Nasal Delivery Devices Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)